This will be a non-comparative prospective observational study of women using Femplant as a primary method of contraception in Pakistan. It will be conducted in close collaboration with the Pakistan MoH and Marie Stopes Society, Pakistan in several MoH-affiliated and Marie Stopes Society clinics that have experience with implants and sufficient expected flow of implant users per month. We will enroll a total of 600 women divided into two cohorts in this one-year prospective study:
- a prospective cohort consisting of 300 women who will be followed-up 3 and 12 months after enrolment; and
- a surveillance cohort of 300 women who will report back to the clinic during 12 months after enrolment only if they have complications, medical problems, pregnancy, or want to remove the implant
The main study outcomes are pregnancy, immediate and delayed complications associated with insertion or removal, adverse events, early discontinuation and reasons for discontinuation, and level of women’s satisfaction with Femplant services.
Article source: http://clinicaltrials.gov/ct2/show/NCT01463254?term=hiv&lup_s=05%2F30%2F2012&lup_d=30
Related posts
- French men defy ban on gay marriage
- A Single Dose Escalation Study to Investigate the Safety, Tolerability and Pharmacokinetics of Intramuscular and Subcutaneous Long Acting GSK1265744 in Healthy Subjects
- Watch: Alan Chambers Compares Homosexuality To Obesity
- Pilot Study of Diflunisal in HIV-infected Adults
- A Phase 3, Open-label Study to Investigate the Efficacy and Safety of GS-7977 Plus Ribavirin in Chronic Genotype 1, 2 and 3 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-infected Subjects
- Pediatric HIV Disclosure Intervention
- What to do This Weekend: Family Fishing Celebration
- Oregon marriage equality supporters considering 2012 state ballot measure
- HIV Disrupts Blood-Brain Barrier
- Help a gay: The Gay Stare
